Clinical Trials Directory

Trials / Completed

CompletedNCT04314661

Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis

Innovative Osteoarthritis Therapy Using Combination of Mesenchymal Stem Cell (MSC) and Conditioned Medium (CM): A Comparative Study on Arthroscopy and Non-Arthroscopy

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
31 (actual)
Sponsor
PT. Prodia Stem Cell Indonesia · Industry
Sex
All
Age
55 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the efficacy of Umbilical Cord Mesenchymal Stem Cell and secretome between arthroscopy and without arthroscopy intervention in OA patients. This study has 4 arms namely Arthroscopy + Booster, Arthroscopy + Pre-conditioning, Non-Arthroscopy + Booster, Non-Arthroscopy + Pre-conditioning.

Detailed description

The study subjects each group amounted to 5 patients suffering from osteoarthritis. Patients are evaluated before, and 1,3,6 months after injection.

Conditions

Interventions

TypeNameDescription
BIOLOGICALArthroscopy with Mesenchymal Stem Cells + Secretome + SecretomeAfter Arthroscopy intervention, patient recieve 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, two weeks afterward, patient receive 2 cc Secretome, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.
BIOLOGICALArthroscopy with Secretome + Mesenchymal Stem Cells + SecretomeAfter Arthroscopy intervention, patient recieve 2 cc Secretome, two weeks afterward patient receive 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.
BIOLOGICALNon Arthroscopy with Mesenchymal Stem Cells + Secretome + SecretomeWithout Arthroscopy intervention, patient recieve 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, two weeks afterward, patient receive 2 cc Secretome, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.
BIOLOGICALNon Arthroscopy with Secretome + Mesenchymal Stem Cells + SecretomeWithout Arthroscopy intervention, patient recieve 2 cc Secretome, two weeks afterward patient receive 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.

Timeline

Start date
2020-08-03
Primary completion
2024-07-08
Completion
2024-12-08
First posted
2020-03-19
Last updated
2026-02-25

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04314661. Inclusion in this directory is not an endorsement.